RPL30P5

Across TCGA pan-cancer cohorts, RPL30P5 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RPL30P5 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RPL30P5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL30P5 expression acts as an unfavorable survival marker, although some lineages such as READ and LUAD show a favorable association.

MESO, ACC, and COAD are the cancer types where RPL30P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.227	0.565	<.001	126	view →
ACC	DFS	Tertile	All	0.092	0.674	<.001	72	view →
COAD	OS	Tertile	II,III,IV	0.660	0.806	.009	66	view →
CESC	OS	Tertile	III,IV	0.206	0.674	.045	36	view →
SKCM	DFS	Tertile	All	0.618	0.742	.007	27	view →
READ	DFS	Tertile	All	0.931	0.425	.017	24	view →
UVM	OS	Tertile	All	0.362	0.737	.039	21	view →
STAD	DFS	Quartile	All	0.360	0.569	.012	10	view →
BLCA	DFS	Tertile	IV	0.173	0.371	.040	9	view →
GBM	OS	Tertile	All	0.187	0.428	.042	9	view →
THCA	DFS	Tertile	II,III,IV	0.786	0.911	.035	9	view →
LUAD	DFS	Tertile	II,III,IV	0.885	0.531	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RPL30P5–MESO (OS)

Open the MESO breakdown →